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ABSTRACT
Background: Poly cystic ovary syndrome (PCOS) is the principal cause of
anovulatory infertility.Adropin is a nutrient-regulated metabolic hormone shown to
encourage glucose oxidation over fatty acid oxidation.Vaspin expression in visceral
adipose tissue is associated with metabolic derangement in rat model of obesity and
T2DM.Some studies addressed adropin and vaspin levels in PCOS, however, the
results are controversial.
Aim of the study: This study was designed to evaluate both serum adropin and
vaspin levels in obese rats with PCOS and to detect any possible association of these
levels with metabolic and hormonal changes in this condition with and without
metformin treatment.
Material and Methods: Twenty four female albino rats were divided into three
equal groups. Group I:Control,Group II:obese rats with PCOS fed HFD for 9 weeks
and given letrozole(1mg/kg BW)by gavage daily for the last 21 consecutive
days.Group III:Metformin pretreated obese PCOS rats,at a dose of 200
mg/kgBWdaily along with letrozole for the last 21days.At the end of the
experiment,Serum
adropin,vaspin,sex
hormones,insulin,glucose,lipid
profile,TNF,plasma D-dimer and ovarian MDA levels were estimated.BMI, HOMAIR were calculated.Ovarian histopathology was done.
Results: Obese PCOS group showed significantly lower serum adropin and higher
vaspin levels when compared to control group.Metformin pretreated group showed
significantly higher serum adropin and lower vaspin levels when compared to obese
PCOS group.Adropin was negatively correlated with all parameters except sex
hormones.Vaspin was positively correlated with all parameters except sex hormones
in all groups.
Conclusion: Adropin and vaspin may represent a novel link between obesity and
metabolic disturbance in obese PCOS rats.
Keyword:Adropin,vaspin,obesity,PCOS,metformin.

INTRODUCTION
COS is a common endocrine disorder
affecting 6-18 % of women of
reproductive age.It is usually associated with
insulin
resistance
(IR),
obesity,
hyperlipidemia, with increased prevalence of
type II diabetes (T2DM), however, the exact
mechanisms underlying PCOS are not clear
[1].
Adropin is a peptide hormone consists of
76 amino acids and expressed in liver and
brain. It is concerned with glucose and lipid
metabolism, adiposity and insulin resistance.
Treatment with adropin can decrease blood
glucose and improve insulin resistance in type
2 diabetic rats [2].
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Vaspin has been known as a visceral
adipose tissue-derived serine protease
inhibitor. Its circulating level markedly
increases in obese individuals. In overweight
women with PCOS and insulin resistance,
metformin decreases serum vaspin levels in
parallel to improvement of insulin sensitivity
[3].
In addition, vaspin has been reported to
have
anti-inﬂammatory
actions,
as
administration of this adipokine suppresses
circulating
TNFα.
demonstrating
the
inhibitory effects of vaspin on cytokineinduced expression of proinflammatory
molecules in vascular endothelial cells [4].
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Therefore, adropin and vaspin may be
involved in the pathogenesis of obesity and
PCOS.Some studies have found a link
between adropin & vaspin levels and PCOS.
However, these studies are limited and
controversial [5].
Metformin is a synthetically derived
biguanide used in treatment of metabolic
disorders and insulin resistance in PCOS. It
was found that metformin ameliorates
reproductive abnormalities and restores
cyclicity & ovulation in women with
PCOS.Yet the effect of metformin on adropin
and vaspin levels in PCOS patients is still
unclear [6].
This study was designed to evaluate both
serum adropin and vaspin levels in obese rats
with PCOS and to detect any possible
association of these levels with metabolic and
hormonal changes occurring in this condition
with and without metformin treatment.
MATERIAL AND METHODS
This study was carried out on 24 female
of local strain albino rats 6 weeks old
weighing 90-105gm.They were obtained from
the animal house faculty of veterinary
medicine Zagazig University.
The rats were kept in steel wire cages
(6/cages) in the animal house of the faculty of
medicine Zagazig University under hygienic
conditions.The rats had free access to water
and chow, were kept at room temperature on a
12 h light/ dark cycle.
The study design was approved by
Institutional Review Board (IRB) NO.4289-42-2018, faculty of medicine, Zagazig
University. All animal experiments were with
the ARRIVE guidelines and carried out in
accordance with the U.K. Animals (Scientific
Procedures) Act, 1986 and associated
guidelines, EU Directive 2010/63/EU for
animal experiments.
The animals were randomly divided into
3 equal groups: Group I : Control group
(n=8), fed on commercial rat standard chow
consisted
of
25.8% protein, 62.8%
carbohydrates and 11.4% fat,Group II:
Experimentally induced obese rats with PCOS
(n = 8), those rats fed high fat diet (HFD) for
9 weeks [7] and given letrozole by gavage
(1mg/kg BW dissolved in 1% carboxy
Wesam M., et al…
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methyl cellulose) daily for the last 21
consecutive days [8].Group III: Metformin
pretreated experimentally induced obese rats
with PCOS(n = 8),treated with metformin(200
mg / kg BW) dissolved in distilled water
daily along with letrozole for the last 21
days [9].
Smears were obtained daily by vaginal
washing with saline daily at 10 am and
evaluated under the microscope. Cycles with
duration of 4 to 5 days were considered
regular estrus phases and were determined
according to Marcondes et al.[10] and
Goldman et al.[11] as follow:
The proestrus phase: the vaginal smear
consists of apredominance of nucleated
epithelial cells with smooth margins,the estrus
phase: the vaginal smear shows large
anucleated cornified (keratinized) cells with
irregular margins,the met estrus phase: the
vaginal smear shows many cornified cells
plus infiltration of leukocytes and the diestrus
phase: the vaginal smear shows absence of the
cornified cells and presence of small
leukocytes.
The observation of cornified cells in the
smears during a minimum of 10 consecutive
days was defined as persistent estrous,
indicating anovulation and development of
follicular cysts[8].
Twenty four hours after the end of the
study (after the last dose of letrozole), and
after overnight fasting, rats weighed and BMI
and AC/TC ratio were calculated according to
the equation: body weight (gm)/length2 (cm2)
[12].
Rats were anaesthetized by ether
inhalation, blood samples were collected from
orbital sinus (sampling of controls taken in
the estrus phase) and ovaries were dissected
and immediately fixed in 10% buffered
formalin. Each blood sample was divided as
follow:
1mL of the blood was collected in a citrated
tube,centrifugated at 3000 rpm for 15 min.
The supernatant plasma was immediately
used for determination of D-dimmer levels
[13] and the remaining amount of the blood
was allowed to clot. Serum was separated by
centrifugation of blood at 3000 rpm for 15
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minutes and stored at -20c until used for assay
[14].
Serum was examined for adropin levels
using rat adropin ELISA Kit (Catalog
number:E-EL-R2566, MyBiosource, USA)
according to the instruction of the
manufacturer.
Serum vaspin levels was determined by
using rat ELISA kits from Wkea Med
Supplies Corp., (USA), according to Hida et
al [15].
Glucose level was determined according
to Tietz[16] using glucose enzymaticliquizyme rat kits (Biotechnology, Egypt) and
insulin level was estimated according to
Temple et al.[17].
Lipid profile was estimated as follows:
Total serum cholesterol level: according to
Tietz [16] ,serum TG level: according to
Fossati [18] , serum HDL levels according to
Nauck et al. [19] and serum LDL levels was
calculated according to Friedewald et al. [20]
as follows: LDL = TC -HDL – TG/5 (Kits for
estimation of serum insulin, cholesterol, TG
and HDL levels were purchased from
Biosource Europe S.A.Belgium).
LH, FSH, estradiol, progesterone and free
testosterone levels were detected according to
Tietz [16] using rat kits: BC-1031, BC-1029,
BC-1111,
BC-1113
and
BC-1115,
respectively, Bio Check Inc 323 Vintage Park
Dr. Foster City.
Serum Tumor Necrosis Factor- α (TNFα) was determined according to Fernando et
al. [21] using KRC3011 rat kits, BioSource
International Inc. 542 Flynn Road Camarillo,
California 93012 USA.
Ovarian lipid peroxidation (MDA) was
estimated according to Ohkawa et al.[22].
Plasma D-dimer levels was detected by
ELISA kit, GenWay Biotech, Inc, ca 40-88234402, USA according to Declerck et al.
[23]
Homeostatic model assessment of insulin
resistance index (HOMA-IR) was calculated
according to the formula described by Sun et
al. [24] as follows:
[HOMA-IR] = fasting serum glucose
(mg/dl) × fasting serum insulin (μIU/ml)/405.

Wesam M., et al…
Published by Arab Journals Platform, 2021

March. 2021 Volume 27 Issue 2

Histopathological examination: The
abdominal cavities of the rats were opened.
Ovaries were dissected and fixed in 10%
buffered formalin for 6 hours at room
temperature and washed in a phosphate buffer
saline solution.For light microscopy,fixed
tissues were dehydrated in an ascending series
of ethanol, cleared in xylene and embedded in
paraffin.5 µm thick sections were mounted in
slides
previously
treated
with
3aminopyropyl triethoxysilane and stained
with
hematoxylin-eoisin
preliminary
observation [25]. The pathologist was blinded
to the treatment.
Statistical analysis:
Results were presented as mean ±
standard deviation (SD). Statistical analysis of
differences between groups was performed
using one way analysis of variance
(ANOVA). Pearson's correlation analysis was
performed to screen potential relations
between serum adropin and vaspin and all
parameters. For all statistical tests done, P
value < 0.05 was considered to be statistically
significant. SPSS version 22 (SPSS Inc.,
Chicago, IL, USA).
RESULTS
In group II (obese pco group), while the
mean values of final BMI, final AC/TC ratio,
serum vaspin, glucose, insulin, HOMA- IR,
triglycerides,
total
cholesterol,
LDLcholesterol, TNF-α, MDA, LH, testosterone
and plasma d-dimer levels were significantly
high (P<0.001 for all), the mean values of
serum adropin,estradiol,progesterone and
HDL-cholesterol were significantly low
(P<0.001) in comparison to those of group I
(control group) (Table 1).
However, the mean values of serum FSH
levels showed non-significant change when
compared with those of group I (P > 0.05)
(Table 1).
Moreover, in group III, metformin
administration resulted in a significant
decrease in vaspin, LH, testosterone, glucose,
insulin, cholesterol, triglycerides, LDL levels,
BMI and calculated HOMA-IR, TNF-α in
addition to ovarian MDA and plasma D-dimer
(p<0.001 for all), but significantly increased
adropin, estradiol, progesterone and HDL (P
value: < 0.01, < 0.001, < 0.001 < 0.01
195 | P a g e
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respectively) when compared to group II
(Table 1).
As regards the correlation with adropin
levels, final BMI, final AC/TC ratio, serum
glucose, insuln, HOMA-IR, total cholesterol,
TG, LDL, TNF-α, plasma D-dimer, ovarian
MDA were significantly negatively correlated
with adropin in all studied groups. Where as,
serum HDL levels were significantly
positively correlated with adropin in all
studied groups (Tables 2).
While final BMI, final AC/TC ratio,
serum glucose, insuln, HOMA-IR, total
cholesterol, TG, LDL, TNF-α, plasma Ddimer, ovarian MDA were significantly
positively correlated with vaspin in all groups
and serum HDL levels were significantly
negatively correlated with vaspin in all groups
(Tables 3).

Finally, there was a significant negative
correlation between serum adropin and vaspin
in all studied groups.
Histopathological examination: Ovaries
from the control group had follicles in
various stages of development including
secondary follicles, graafian follicles, and
recently formed corpus luteum surrounded by
normal ovarian stroma (photo 1).Ovaries from
PCO rats showed increased numbers of large
cystic follicles, and the cystic wall was
thickened, characterized by a thickened theca
cell layer and a diminished granulosa cell
layer with no antral follicles or corpus luteum
indicating anovulation (photo 2). Ovarian
tissue from group III
shows decreased
number of cystic follicles and increased
thickness of granulosa cell lining in addition
to the appearance of several follicles at
different developmental stages (photo 3).

Table (1):The mean  SD of all measured parameters in all studied groups
Groups
Parameters
adropin (ng/mL)
vaspin (ng/mL)
final BMI (gm/cm2)
final AC/TC ratio
glucose (mg/dl)
insulin (µIU/ml)

  SD
  SD
  SD
  SD
  SD
  SD

Group I
( control)
29.14±4.5
0.4 ± 0.07
0.49 ± 0.008
1.13 ± 0.01
78.88±10
7.67±0.58

Group II
(Obese PCOS)
14.79±1.4 a ***
3.8±0.46 a ***
0.93±0.04 a ***
1.55 ± 0.02 a ***
192.5±3.6 a ***
28.7±1.08 a ***

Group III
(Obese PCOS+metformin)
20.25 ± 1.28 a *** b **
1.04 ± 0.26 a ** b ***
0.75 ± 0.03 a *** b ***
1.33± 0.02 a *** b ***
142.13 ±8.2 a *** b ***
12.4 ± 1.07 a *** b ***

1.52± 0.29
13.65±0.75
4.38± 0.62
  SD
a ***
68.4 ±14.6
261.2 ±17.5
110.5 ± 16.2 a *** b ***
  SD
a ***
73.75 ± 9.4
192.4±14.2
112.6 ± 12.16 a *** b ***
  SD
51.25±6.5
29.5±3.3 a ***
36.6 ± 3.03 a *** b **
  SD
78.5 ± 8.3
167.5 ±13.33 a ***
89.25 ± 6.6 a * b ***
  SD
7.03 ± 0.2
6.8 ± 0.4
6.93 ± 0.23
  SD
a ***
2.1 ± 0.37
6.7± 0.59
4.6 ± 0.31 a ***b ***
  SD
a ***
77.1 ± 0.42
244.2 ± 0.55
139.6 ± 7.1 a *** b ***
  SD
36.33±2.29
14.71±.1.8 a ***
28 ± 2 a *** b ***
  SD
7.94 ± 0.33
4.76±0.49 a ***
5.8 ± 0.57 a *** b ***
  SD
a ***
13.22±1.5
86.38 ±7.6
45.25 ± 6 a *** b ***
  SD
86.13±2.9
181.5±7.34 a ***
110 ± 7.8 a *** b ***
  SD
a ***
58.4±2.3
207.2± 5.1
140 ± 7.15 a *** b ***
  SD
a = versus group I, b = versusgroup II, * = significant (P<0.05), ** = significant (P<0.01), *** = significant
(P<0.001)
BMI:body mass index, AC/TC ratio:abdominal circumference/thoracic circumference ratio,
HOMA-IR: Homeostatic model assessment of insulin resistance index, HDL:high density lipoprotein, LDL:
low density lipoprotein, FSH: follicular stimulating hormone, LH:Lutenizing hormone, TNF-α: Tumor
Necrosis Factor- α, MDA: Ovarian lipid peroxidation
HOMA-IR
total cholesterol (mg/dl)
triglycerides(mg/dl)
HDL (mg/dl)
LDL (mg/dl)
FSH (IU/ml)
LH (IU/ml)
testosterone (pg/ml)
estrogen (pg/ml)
progesterone (ng/ml)
TNF-α (pg/ml)
MDA (mmol/gm)
D-dimer (mg/dl)
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Table (2):Correlation between serum adropin levels and the levels of the other measured
parameters
Parameters

BMI (gm/cm2)
AC/TC ratio
LH (IU/ml)
FSH (IU/ml)
Estradiol (pg/ml)
Progesterone (ng/ml)
Testosterone (pg/ml)
Glucose (mg/ dl)
Insulin (μIU/ml)
HOMA-IR
TC
TG
HDL
LDL
TNF-α
MDA
D-dimer
vaspin

Group I (Control )
r
-0.931*
-0.952 ***
-0.275
0.256
0.059
0.236
-0.089
-0.955***
- 0.899 **
- 0.989 ***
- 0.957 ***
- 0.903***
0.954 ***
-0.978 ***
- 0.952 ***
-0.956 ***
-0.985 ***
-0.987***

Group II ( Obese
PCOS)
r
-0.947***
-0.969 **
-0.132
0.145
0.21
-0.594
-0.2
-0.937**
-0.982***
-0.984***
-0.988***
-0.953***
0.95***
-0.976***
-0.977***
-0.976***
-0.97***
-0.952***

Group III (Obese PCOS+metformin)
r
-0.91*
-0.944***
-0.169
0.313
-0.557
-0.261
-0.199
-0.959***
-0.92***
-0.957***
-0.957***
-0.946***
0.975***
-0.977 ***
-0.958***
-0.926***
-0.966***
-0.884***

r:Correlation coefficient * = significant (P<0.05); ** = significant (P<0.01); *** = significant
(P<0.001)

Table (3): Correlation between serum vaspin levels and the levels of the other measured
parameters.
Parameters

BMI (gm/cm2)
AC/TC ratio
LH (IU/ml)
FSH (IU/ml)
Estradiol (pg/ml)
Progesterone (ng/ml)
Testosterone (pg/ml)
Glucose (mg/ dl)
Insulin (μIU/ml)
HOMA-IR
TC
TG
HDL
LDL
TNF-α
MDA
D-dimer
Adropin

Group I (Control )
r
0.921*
0.918 ***
0.354
-0.309
0.062
-0.158
0.27
0.985 ***
0.863 **
0.992 ***
0.974 **
0.947 ***
- 0.982***
0.963***
0.984 ***
0.979 ***
0.986***
-0.987 ***

Group II ( Obese
PCOS)
r
0.972***
0.949***
0.16
-0.063
0.276
-0.466
0.15
0.962 ***
0.931 **
0.96 ***
0.95 ***
0.944 ***
- 0.951***
0.984***
0.977***
0.95***
0.955***
-0.952***

Group III (Obese PCOS+metformin)
r
0.87**
0.793*
0.76
0.124
0.437
0.383
0.505
0.921**
0.887**
0.908**
0.92**
0.93**
- 0.843**
0.893**
0.904**
0.901**
0.909**
-0.884***

r:Correlation coefficient * = significant (P<0.05); ** = significant (P<0.01); *** = significant
(P<0.001)
Wesam M., et al…
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(A)
Photo (1): Ovarian tissue from group I (H&E × 200)

¥
*

(B)

( A ) ( H & E × 200 )
(B) (H&E ×400)
Photo (2): Ovarian tissue from group II
(* ) very thin layer of granulosa cell
( ¥ )hyperthecosis of the stroma

B

←

Photo (3): Ovarian tissue from group III (H & E × 200)
(←) increased thickness of granulosa cell lining ( A & B ).
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DISCUSSION
The results of this work showed that HFD
for 9 weeks started at age of 6 weeks (to
produce early onset obesity) was found to
induce a significant increase in BMI and
AC/TC ratio denoting occurrence of obesity
in addition to insulin resistance and
dyslipidemia in rats of group II compared
with control.
The signs of PCOS induced by letrozole
in obese rats was proved by the significant
hyperandrogenism
accompanied
by
significant reduction in both estradiol and
progesterone levels in comparison to control
group, in addition to persistent estrus
observed in vaginal smear and multiple
ovarian cysts detected in histopathological
examination, as letrozole blocked cytochrome
P450 aromatase which is essential for
aromatization of testosterone to estradiol [26].
Interstingly,
metformin
treatment
significantly reduced BMI and AC/TC ratio in
group III.Metformin’s effects on body weight
may be due to its anorexigenic effect via
pathway involving neuropeptide Y in human
& animal models and pancreatic polypeptide
in human subjects in addition to its insulin
sensitizing effect [1].
Regarding serum adropin, there was a
significant decrease in its levels in obese
PCOS rats compared with controls. However,
treatment with metformin significantly
increased these levels in group III.
Furthermore,
a
significant
negative
correlation was found between adropin levels
and BMI, and AC/TC ratio in all groups.
In line with these findings, Kume et al.
[27] found that serum adropin levels were
significantly decreased in lean and obese
PCOS and were negatively correlated with
BMI and waist circumference. The decreased
adropin levels could be explained by results
who reported that chronic exposure to HFD
resultrd in reduced expression of adropin
levels, perhaps revealing deregulation of liver
Enho gene with obesity [2].
In the present study, obese PCOS rats
showed significantly higher serum levels of
glucose and insulin, TC, TG and LDL in
addition to HOMA-IR index when compared
with control rats, while, there was a
Wesam M., et al…
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significant decrease in HDL levels in the
same group.Treatment with metformin
produced a significant decrease in fasting
serum levels of glucose, insulin, TC, TG,
LDL and HOMA-IR associated with a
significant increase in HDL levels in group III
when compared with group II.
In addition, there was also a significant
negative correlation between serum adropin
level and glucose, insulin, TC, TG, LDL
serum levels, and HOMA-IR in all groups,
while a significant positive correlation
between serum adropin and HDL levels was
found.
These results are in line with other study
which showed that serum adropin levels were
positively correlated with HDL-C levels and
negatively correlated with LDL-C levels in
women with polycystic ovary syndrome [28].
In this study, serum level of TNF-α was
significantly higher in obese PCOS group
compared with control group. However,
treatment with metformin produced a
significant decrease in TNF-α. Furthermore,
there was a negative correlation between
adropin and TNF-α in all groups.This is in
accordance with Ghowsi et al. [29] who
reported that PCOS is a chronic low grade
inflammatory disorder characterized by
increased levels of pro inflammatory
cytokines, IL-6 and TNF-α.
So, increased inflammatory condition
could be due to reduced adropin level as
adropin decreased the mRNA expression
levels of TNF-𝛼 and IL-6 in the pancreas of
diabetic rats and may play a protective role in
diabetic nephropathy development through
anti-inflammatory effects [30].
In this work, a significant increase in
levels of ovarian tissue MDA was found in
obese PCOS group compared with controls.
While metformin treatment produced a
significant decrease in these levels. In
addition, a significant negative correlation
between adropin and MDA was found in all
groups.
This study supposed that increased
oxidative stress in obese PCOS rats could be
due to reduced adropin level .This could be
supported by the finding that the reduced
plasma adropin levels in aged rats were
199 | P a g e
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associated with increased oxidative stress
markers in the brain [31].
The present study found a significant
higher levels of D- dimer in obese PCOS
group compared with controls, while,
metformin treatment produced a significant
decrease in those levels. Furthermore, a
significant negative correlation between
adropin and D- dimer was found in all groups.
The relationship between adropin and Ddimer proved in our study can be supported
indirectly by other studies showed decreased
adropin levels in coronary artery disease
While, chronic administration of adropin
weakened the development of atherosclerotic
lesions in the aorta, with reduction in the
monocyte/macrophage infiltration and smooth
muscle cell content inside the plaque [32].
Regarding vaspin, there was a
significantly higher circulating level in obese
PCOS rats compared with controls, while,
metformin treatment produced a significant
decrease in these levels. Furthermore, there
was a significant positive correlation between
vaspin and BMI & AC/TC ratio in all groups.
This increased levels can be explained by
diet induced obesity as vaspin is mainly
expressed in visceral adipose tissue [33].
The results of the present work also
showed that circulating vaspin levels were
positively correlated with circulating levels of
glucose, insulin and HOMA-IR in all groups.
Our study suggested that the increased
vaspin level may be a compensation for the
disturbed glucose metabolism in obese PCOS
group. This notion is supported by Hida et
al.[15] who reported that administration of
vaspin to obese mice fed with H.F.D.
improved glucose tolerance and insulin
sensitivity reflected by normalized serum
glucose levels.
After metformin treatment, there was a
significant decrease in serum vaspin levels.
This result is supported by Tan et al.[34] who
reported that Metformin therapy through
improving insulin sensitivity and decreasing
in circulating glucose levels, caused decrease
in serum vaspin levels as glucose was found
to cause a significant dose dependent increase
in vaspin production and secretion from
human omental adipose tissue, which
Wesam M., et al…
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indicates that vaspin is induced by
hyperglycemia and explains the significant
correlation between vaspin and glucose levels
in the current study.
Regarding the relationship between
circulating vaspin levels and lipid profile in
this study, circulating vaspin levels were
found to be positively correlated with TG,
TC, LDL-C and negatively correlated with
HDL in all groups. Our finding comes in
agreement with other study that reported
positive correlation between vaspin levels and
triglycerides levels in controls and obese
subjects [35].
Our study suggested that the increased
vaspin level may be a compensation for the
disturbed lipid metabolism in obese PCOS
group. This supported by Gao et al. [36] who
reported that vaspin is known to suppress
development of atherosclerosis via its
antilipidemic properties and also suppress
cholesterol efflux.
Additionally, the present study found a
significant positive correlation between
vaspin and TNF-α levels in all groups.The
increased vaspin levels in group II might be a
compensation for inflammation through its
anti-inflammatory, anti-apoptotic, properties
and as through its activity as a serine protease
inhibitor. Consistent with this, it was reported
that vaspin inhibited the expression of pro
inflammatory cytokines; leptin, resistin and
TNF- α in white adipose tissue [37].
Additionally, the present study found a
significant positive correlation between
vaspin and ovarian tissue MDA levels in all
groups.This relation can be explained by the
inhibitory effect of vaspin on ROS generation
and NADPH oxidase activity [38].
Also, the present study found a
significant positive correlation between
vaspin and D-dimer levels in all groups.
Experiments also indicated that vaspin could
inhibit the release of many inflammatory
markers in vascular smooth muscle cells and
reduce FFA-induced apoptosis in endothelial
cells [39].
In the present study, we did not find any
significant correlations between serum levels
of adropin & vaspin and testosterone,
estrogen, progesterone, FSH or LH in all
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groups. Our findings suggest that vaspin
levels in PCOS might be affected by factors
other than disturbance in the hormones of
pituitary ovarian axis, and in turn this
adipokine not affect those hormones directly
Finally, there was a significant negative
correlation between adropin and vaspin levels
in all groups. This finding can suggest that
vaspin might decrease serum adropin levels as
explained indirectly by results of
who
concluded that vaspin regulates the genetic
expression of hormones involved in the
pathogenesis of metabolic disorders, such as
leptin, resistin and adiponectin [15].
In Conclusion, Adropin and vaspin may
represent a novel link between obesity and
metabolic disturbance in obese PCOS rats.
Since these hormones have been associated
with obesity, IR, inflammation, oxidative
stress and hypercoagulability in those rats.
Furthermore, adropin and vaspin may be
involved in the beneficial effects of
metformin in case of PCOS associated with
obesiy.
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